Evaluation of the mirn23a Cluster through an iTRAQ-based Quantitative Proteomic Approach by Ludwig, Katelyn R. et al.
Evaluation of the mirn23a Cluster through an iTRAQ-based 
Quantitative Proteomic Approach
Katelyn R. Ludwig1,2, Richard Dahl2,3,4, and Amanda B. Hummon1,2,*
1
 Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, USA
2
 Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN, USA
3Department of Microbiology and Immunology, Indiana University School of Medicine, South 
Bend, IN, USA
4Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA
Abstract
MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression that are implicated in 
a number of disease states. MiRNAs can exist as individual entities, or may be clustered and 
transcribed as a single polycistron. The mirn23a cluster consists of three miRNAs, miR-23a, 
miR-24-2, and miR-27a. While these miRNAs are transcribed together, they often exist at varying 
levels in the cell. Despite the fact that the mirn23a cluster is known to play a role in a number of 
diseases and developmental processes, few direct targets have been identified. In this study, we 
examined the effects of miR-23a, miR-24-2, miR-27a, or the mirn23a cluster overexpression on 
the proteome of 70Z/3 pre-B lymphoblast cells. Quantitative mass spectrometry using isobaric tags 
for relative and absolute quantification (iTRAQ) allowed for global profiling of cell lines after 
miRNA overexpression. We identified a number of targets of each miRNA that contained 
predicted miRNA seed sequences and are likely direct targets. In addition, we discovered a cohort 
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of shared miRNA targets and cluster targets, demonstrating the importance of studying miRNA 
clusters in their entirety.
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Introduction
MicroRNAs (miRNAs) are small, endogenous, non-coding RNAs that belong to a large 
family of post-transcriptional regulators of gene expression1,2. MiRNAs are known to 
decrease gene expression through destabilization or degradation of target mRNA transcripts, 
though rare instances of gene up-regulation have been reported3,4,5. The “seed sequence” of 
the miRNA (nucleotides 2-8 of the mature miRNA) binds to 6-8 nucleotides in the 3’ 
untranslated region (UTR) of a target mRNA molecule, resulting in its translational 
inhibition or transcript degradation6,7,8. Cellular roles are thought to vary from minimizing 
protein expression level variability to substantially decreasing expression levels9. Due to the 
relatively promiscuous seed matching requirements of miRNAs, they are predicted to 
regulate over 60% of protein coding genes in mammals10.
Multiple miRNAs often reside in clusters located in close proximity on the chromosome. 
Clustered miRNAs are found within 10 kb of each other, and are usually transcribed as a 
single polycistron with similar abundances11,12. MiRNAs that exist in clusters may possess 
seed sequence homology and have redundant functions. For example, the Mirc19 cluster is 
comprised of miR-212 and miR-132, which together target the transcription factor FOXO3 
to regulate hematopoietic stem cell maintenance13. However, clustered miRNAs often have 
unique seed sequences, and their biological function is less clear. The miR-17-92 cluster 
contains six distinct miRNAs that are highly expressed in many types of cancer. Previous 
studies indicate certain members of the cluster negatively regulate angiogenesis, while others 
promote blood vessel formation, demonstrating the complex nature of these clusters14.
The mirn23a cluster consists of three distinct members: miR-23a, miR-27a, and miR-24-2. 
The mature miRNAs are derived from a single pri-miRNA transcript, but often exhibit 
variable expression levels in the cell15. In addition to mirn23a, a paralogous mirn23b cluster 
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comprised of miR-23b, miR-27b, and miR-24-1 exists in mammals. The mature sequences 
of miR-23a/b and miR-27a/b differ by a single nucleotide outside of their seed sequences, 
while miR-24-1 and miR-24-2 are identical. The two paralogous clusters reside on different 
chromosomes and are transcribed independently, and it is likely they undergo different 
mechanisms of regulation. The biological functions of the mirn23a cluster have been shown 
to play a role in a wide variety of processes, including hematopoietic development16,17,18, 
apoptosis19,20, drug resistance21, tumor suppression22, and oncogenesis23,24,25,26. 
Functional studies been performed to show that overexpression of miR-23a, miR-24-2, or 
miR-27a individually lead to entirely different phenotypic results than the entire mir23a 
cluster, demonstrating the importance of studying the cluster in its entirety27. In addition, 
studies in our group of the miR-143/145 cluster found that certain genes are repressed only 
when all members of the cluster were present, indicating clustered miRNAs can work in a 
synergistic fashion28. The non-random distribution of clustered miRNAs suggests an 
evolutionarily conserved pattern, and thus it is imperative to study both the individual and 
combined functions of clustered miRNAs to discern their physiological roles.
Traditionally, miRNA targets have been studied through bioinformatic predictions and 
transcriptome analysis. A number of predictive algorithms have been created that weigh 
miRNA seed matching, free energy of binding, evolutionary conservation, and other 
parameters to determine miRNA targets29. Bioinformatic analyses are hindered by sequence 
differences in annotated 3’ UTRs, as well as transcript variants among different cell types. 
They often predict thousands of target transcripts that are not confirmed to be 
physiologically relevant. Microarray analysis of mRNA levels after overexpression or 
knockdown of miRNAs reveals hundreds of transcripts with subtly changed expression, but 
overlooks mRNAs that are translationally inhibited without degradation30. Mass 
spectrometry-based proteomics has become an established method to identify protein 
changes, which are the ultimate consequences of miRNA manipulation31,32,33. The addition 
of isobaric tags for relative and absolute quantification (iTRAQ) allows for proteomic 
quantification by mass spectrometry.
In this study we performed global quantitative mass spectrometry to determine the protein 
targets of miR-23a, miR-27a, and miR-24-2 individually and as an intact cluster. Using 
iTRAQ labeling and UPLC-MS/MS we detected between 60-160 proteins downregulated by 
each miRNA. We also found a number of proteins that only showed significant 
downregulation when the entire mirn23a cluster was expressed in concert.
Our results support previous findings that miRNA clusters work synergistically to target 
genes that are not repressed by any of the individual miRNAs, and highlight the importance 
of studying miRNA clusters in their entirety.
Materials and Methods
Reagents
Cell culture reagents and phosphate buffered saline (PBS) were obtained from Invitrogen 
(Gaithersburg, MD). Fetal bovine serum (FBS) was purchased from Hyclone. Protease 
inhibitor cocktail was purchased from Roche Diagnostics (Indianapolis, IN). Trypsin Gold 
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(Mass Spectrometry Grade) was purchased from Promega (Madison, WI). Mass 
spectrometry solvents were obtained from Burdick and Jackson (Muskegon, MI). iTRAQ 8-
plex multiplex kit and buffer kit were purchased from AB Sciex (Framingham, MA). All 
other reagents were acquired from Sigma-Aldrich (St. Louis, MO).
Cell Culture and Protein Harvest
293FT cells were transfected with the murine stem cell virus-GFP (MSCV-GFP) retroviral 
plasmid with retroviral packaging vector pCL-Eco (Imgenex, San Diego, CA). Viral 
supernatants were harvested, concentrated with Centricon Plus-70 filters (Millipore, 
Billerica, MA), and transduced into 70Z/3 cells. Stable cell lines were created by sorting for 
GFP+ cells. MiRNA expression is controlled by the long terminal repeat (LTR) promoter 
contained in the MSCV-GFP plasmid. Cells were grown in RPMI 1640 supplemented with 
10% FBS, 1mM HEPES, 2 mM L-glutamine, 1mM sodium pyruvate, and 55µM 2-
mercaptoethanol (BME). Cell pellets were rinsed with PBS before lysis in 500mM TEAB, 
0.1% SDS, 1mM NaF, 1mM β-glycerophosphate, and 1mM Na3VO4 with one tablet of 
protease inhibitor cocktail. Lysates were sonicated twice for 60 seconds at 10% amplitude, 
with a rest of 60 seconds between. Lysates were then clarified through centrifugation at 4°C 
for 10 minutes at 15,000 RPM. Protein concentrations were determined using a BCA assay 
kit (Thermo Scientific, Waltham, MA) with BSA standards (Thermo Scientific). Three 
biological replicates were harvested for each miRNA-expressing cell line, and the negative 
control. The parental 70Z/3 cell line was analyzed in biological duplicate. 300µg of protein 
from each lysate was combined with six volumes of cold acetone and allowed to precipitate 
for 6 hours at −20°C. After removing the supernatant, pellets were washed with 500µL of 
cold acetone and allowed to air dry for five minutes. Pellets were resuspended in 40µL of 
0.1% SDS in 500mM TEAB and again quantified using a BCA assay. 45µg of each sample 
was taken to continue sample preparation.
Preparation of Mass Spectrometry Samples
Proteins were reduced with 5mM Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) at 
60°C for 1 hour and alkylated with 5mM iodoacetamide for 10 minutes at RT in the dark. 
Proteins were then digested overnight at 37°C with trypsin gold (Promega, Madison, WI, 
USA) at a 50:1 protein to trypsin ratio (w/w) in the presence of 1mM CaCl2. The digestion 
reaction was terminated with the addition of 1mM phenylmethylsulfonyl fluoride (PMSF). 
Sample volumes were reduced to 12 µL through vacuum centrifugation. iTRAQ labels were 
thawed for five minutes at RT and diluted with 50µL of isopropanol. 28µL of iTRAQ label 
was added to each sample and allowed to react at RT for 2 hours. The labeling reaction was 
quenched with the addition of 40mM glycine for 20 minutes at RT. Samples were pooled 
and excess labeling reagents and SDS were removed using an SCX SpinTip sample 
preparation kit (Protea Biosciences, Morgantown, WV) following manufacturer’s 
instructions. High-pH RP fractionation was performed using an Oasis HLB 1cc Vac 
Cartridge with 30mg sorbent and 30µm particle size (Waters Corporation, Milford, MA). All 
buffers used in the separation contained 10mM NH4HCO3 and were adjusted to pH 10 with 
NH4OH. The cartridge was prepared by activating with 2mL of 80%ACN and equilibrating 
with 3mL of 10mM NH4HCO3. Samples were resuspended in 500 µL of 10mM NH4HCO3, 
loaded onto the cartridge, and washed with 3mL of 10mM NH4HCO3. Peptides were 
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fractionated with buffers containing 5, 10, 13, 17, 20, 23, 30, and 80% ACN. All samples 
were desalted with C18 ZipTips (Millipore, Billerica, MA) before LC-MS/MS analysis.
Mass Spectrometry Analysis
Samples were resuspended in 0.1% FA in HPLC grade water. Analysis was performed with 
a nanoACQUITY Ultra Performance LC (UPLC) system (Waters Corporation, Milford, 
MA) coupled to a Q-Exactive mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany). Peptides were loaded onto a BEH C18 reverse phase column (100µm × 100mm, 
1.7µm particle size) (Waters Corporation, Milford, MA) and separated using a binary solvent 
system consisting of 0.1% FA in water (A) and 0.1% FA in acetonitrile (B). The following 
linear gradient was used for all samples: 98-82% A in 95 minutes, 82-60% A in 10 minutes, 
15% A for ten minutes, and equilibrated with 98% A for 10 minutes at 900nL/min. The Q-
Exactive was operated in Top 12 data-dependent mode with automatic switching between 
MS and MS/MS modes. The nanoelectrospray ion source was operated at 1.8kV, and the ion 
transfer tube was at 280°C. Full MS scans were acquired with a resolution of 70,000 and an 
automatic gain control (AGC) target of 1 × 106 ions with a maximum fill time of 250 ms. 
MS1 spectra were acquired from 400-1,800 m/z. MS/MS scans (100-1,500m/z) were 
acquired with a resolution of 35,000 and a maximum fill time of 120 ms. The AGC target 
was set at 1 × 106 ions with an underfill ratio of 0.6% and an isolation window of 2 m/z. 
Ions were fragmented with a normalized collision energy (NCE) of 30.0, and dynamic 
exclusion was set to 40.0 s. Samples with a charge of +1 or greater than +7 were excluded 
from MS/MS analysis. Samples were run with duplicate injections.
Data Analysis
All .raw files were searched using Proteome Discoverer 1.4 software (Thermo Fisher 
Scientific, Bremen, Germany) with MASCOT version 2.2.4 against the UniProt mouse and 
decoy databases (Version 4, June 2012, 59,345 sequences). The following parameters were 
used: trypsin was selected as the enzyme; two missed cleavages were allowed; precursor 
mass tolerance was set to 20ppm and fragment mass tolerance was 0.05 Da. Variable 
modifications included protein N-terminal glutamine deamidation, methionine oxidation, 
acetylation, and iTRAQ 8plex labels on tyrosine. Static modifications included 
carbamidomethylation of cysteine and iTRAQ 8plex labels at the N-termini and lysine side 
chains. Peptides were filtered for high confidence, resulting in a peptide level false discovery 
rate (FDR) that is less than 1%. Strict maximum parsimony principle was applied 
considering PSMs with a delta Cn better than 0.15. The delta Cn used in Proteome 
Discoverer is distinct from the delta Cn used during data analysis by SEQUEST. The 
integration tolerance window was set to 20ppm, and only unique peptides were considered 
for quantification. Ratios were normalized on protein median for quantification. All analyses 
were performed in Microsoft Excel unless specified otherwise.
Multiple Reaction Monitoring
Samples were prepared as described above omitting the iTRAQ labeling and fractionation. 
Proteins that showed a decrease in expression after miRNA expression were chosen for 
quantification in all cell lines. Peptides that were unique to each protein were identified and 
transition ions were chosen based on empirical data. Three transitions were chosen per 
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peptide. The most intense transitions were used for quantification, while the other two 
transitions served as confirmation of peptide identification. MRM detection was performed 
on a 6500 QTRAP (AB SCIEX, Concord, Ontario, Canada) running in triple quadrupole 
mode. Peptides were loaded onto a HPLC 2D NanoLC Ultra (Eksigent) equipped with a 
Waters Acquity BEH C18 column (100 µm × 100 mm). Peptides were separated using a 96 
minute gradient from 2% solvent B to 30% solvent B, followed by an organic wash and re-
equilibration to 2% B. A flow rate of 533 nL/min was used. The nanospray source operated 
with a curtain gas of 25.0, an interface heater temperature of 150, and an ionspray voltage of 
2300.0. A dwell time of 20ms was used for all runs. Collision energies were calculated 
based on the formulas CE= 0.03 * (precursor m/z) + 3 for triply charged peptides and 0.05 * 
(precursor m/z) + 1 for doubly charged peptides. All samples were analyzed in technical 
duplicate and samples were normalized to the Myosin heavy chain protein to minimize 
variability. Peptide sequences and transitions used for quantification are provided in the 
supporting information.
Quantitative Real Time PCR
Total RNA (including miRNAs) was harvested from all 70Z/3 cell lines using the miRNeasy 
kit (Qiagen, Valencia, CA) according to manufacturer’s instructions. MiRNA expression was 
determined using TaqMan microRNA assays (Applied Biosystems, Foster City, CA). 
MiR-16 was used for expression level normalization. 40 µg of RNA was reverse transcribed 
with the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA) and 3 µL of RT primer. Reverse transcription was performed in a thermocycler for 30 
min at 16°C, 30 min at 42°C, and 5 min at 85°C. PCR samples were prepared in triplicate 
according to the TaqMan assay protocol. Quantitative PCR was performed on a StepOne-
Plus instrument (Applied Biosystems, Foster City, CA). Samples were held at 95°C for 10 
minutes followed by 40 cycles of 95°C for 15 s and 60°C for 60 s.
Gene expression analysis of targets was performed using PerfeCta SYBR Green FastMix 
(Quanta Biosciences, Gaithersburg, MD) on a StepOne-Plus instrument (Applied 
Biosystems, Foster City, CA). Samples were held at 95°C for two minutes followed by 40 
cycles of 95°C for 15s and 60°C for 60s. Reactions were performed in technical triplicate 
and all genes were normalized to GAPDH.
3’ RACE
3’ rapid amplification of cDNA ends was performed to sequence the 3’ UTR of select genes 
as described previously34. Briefly, total RNA was harvested from cell lines as described 
above. Reverse transcription of 5µg of RNA was performed using a primer with the 
sequence 5'–ccagtgagcagagtgacgaggactcgagctcaagcttttttttttttttttt–3' to create a 3’ UTR cDNA 
pool. Gene specific primers were used to amplify the 3’ UTR regions of different genes with 
GoTaq DNA polymerase (Promega) according to manufacturer’s instructions. All primer 
sequences can be found in Table S1. Sanger sequencing of PCR products was performed at 
the Notre Dame Genomics Core Facility.
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Results and Discussion
iTRAQ Proteomics of the mirn23a Cluster
To investigate the protein targets of the mirn23a cluster, murine pre-B lymphoblast 70Z/3 
cells were transduced with a retroviral murine stem cell virus (MSCV) vector to stably 
express miR-23a, miR-27a, miR-24, or the entire cluster in tandem27. The mature sequences 
of the miRNAs can be seen in Figure 1A. Cells containing a negative control MSCV-GFP 
retrovirus and parent 70Z/3 cells were also analyzed. Overexpression of miRNAs in each 
cell line was confirmed using TaqMan RT-PCR (Figure 1B). Protein fold changes between 
cells transduced with miRNAs and cells containing a negative control vector were calculated 
based on iTRAQ tag intensities. The intensities of iTRAQ reporter ions, as well as peptide 
identification information, are detected in the tandem spectra acquired in a mass 
spectrometry run (Figure S1). This allows for protein identification and calculation of fold 
change ratios without complicating MS1 spectra. We performed four separate iTRAQ 
experiments to examine each cell line in biological triplicate. Replicates of parent 70Z/3 
cells were included in each experiment as a control for variation. Proteins were harvested 
from cells and digested overnight with trypsin. The resulting peptide mixtures were labeled 
with eight-plex iTRAQ tags. After sample pooling, peptides were separated into eight 
fractions using high-pH reverse-phase separation, followed by low-pH UPLC-MS/MS 
coupled to a Q-Exactive mass spectrometer. An overview of the experimental procedure is 
shown in Figure 2.
Each experiment identified and quantified approximately 2,000 proteins at a 1% false 
discovery rate (FDR), resulting in a combined total of 3,051 proteins. Between 10,736 and 
11,848 peptides were identified in each experiment, with an average of 45,144 peptide 
spectral matches (Table 1). The overlap between experiments can be seen in Figure S2. The 
log2 fold change distributions were plotted and found to be centered around zero, indicating 
that the majority of quantified proteins did not change in abundance after miRNA 
overexpression (Figure 3). These subtle abundance changes agree with previous reports 
demonstrating that miRNAs have modest effects on global protein levels31,32. The log2 fold 
changes of parent cell line replicates were compared to determine the inherent biological and 
experimental variation. The fold changes were distributed around zero with a standard 
deviation of 0.16. (Figure S3). Because miRNAs are known to subtly alter protein 
expression, the threshold for differentially expressed proteins was set at two standard 
deviations from the mean (log2 fold change ≤ −0.32 or ≥ 0.32). Following miR-23a, miR-24, 
miR-27a, or mirn23a overexpression, 163, 66, 161, and 124 proteins, respectively, showed a 
significant decrease in expression.
Cumulative Distribution Analysis
MiRNAs are known to repress protein expression by matching their seed sequence to a 
binding site in the 3’ UTR of target mRNAs. A cumulative distribution analysis of 
expression level changes of proteins containing a miR-23a, miR-24, or miR-27a site in their 
3’ UTR regions shows a subtle shift towards repression compared to the overall data set 
(Figure S4). For each miRNA, the list of downregulated proteins is enriched with proteins 
containing miRNA seed sequence matches. The mirn23a cluster data set also shows 
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enrichment for proteins that contain a seed match for at least one of the three members of the 
cluster.
To confirm that this effect is specific to the miRNA expressed in each cell line, we analyzed 
protein expression changes associated with alternate miRNAs from the mirn23a cluster. For 
example, the miR-23a data set was examined for targets that contain miR-27a or miR-24-2 
binding sites. No shift toward repression was seen when targets of alternate miRNAs were 
analyzed, indicating the decrease in protein expression levels were due to miR-23a 
overexpression. A specific shift towards downregulation was also seen in the miR-24 and 
miR-27a data sets. These results demonstrate that the subtle proteomic changes that occur 
after miRNA overexpression are specific to each altered miRNA, and that they exhibit their 
effects through binding sites in the 3’ UTR.
Proteomic Identification of miRNA targets
Putative targets of miR-23a, miR-24, miR-27a, and the mirn23a cluster were determined 
based on the degree of downregulation and presence of a miRNA binding site in the 3’ UTR 
of the target gene. Of the 163 proteins that decreased in expression due to miR-23a, 35 
possess miR-23a binding sites in their 3’ UTR. Ten of the 60 proteins repressed by miR-24, 
and 35 of the 161 repressed by miR-27a, contained predicted miRNA seed matches in their 
3’ UTR (Figure 4A-C). The presence of a seed match indicates a strong likelihood these 
genes are direct targets of the corresponding miRNAs. As an example, DHFR, which was 
previously confirmed as a target of miR-24, was downregulated35.
Shared miRNA targets are genes that are repressed by more than one miRNA acting 
individually, but originally derived from a cluster28. A cohort of shared targets was evident 
when the proteins repressed by individual miRNAs were considered (Figure 4D). Shared 
targets are expected for miR-23a and miR-27a because their seed sequences differ by only a 
single nucleotide. Indeed, 13 proteins showed similar magnitudes of downregulation when 
either miRNA was expressed. Twenty proteins showed decreased expression by miR-23a or 
miR-24 overexpression. miR-24 and miR-27a have two shared targets, and one gene, 
NUDT2, showed repression in all three data sets. The Nudt2 gene encodes the 
Bis(5’nucleosyl)-tetraphosphatase enzyme, and which hydrolyzes di-adenosine 
tetraphosphate (Ap4a) to yield AMP and ATP. It has been identified as a potential tumor 
suppressor gene in humans36. Though the seed sequences of miR-23a and miR-27a are 
distinct from miR-24, the 3’ UTR of mRNAs contain many miRNA binding sites. Therefore, 
it is not unexpected for non-homologous miRNAs to exhibit regulatory effects on the same 
proteins.
Additionally, a number of targets only showed significant downregulation when all three 
members of the cluster were present, classifying them as cluster targets (Figure 5)28. Most 
targets showed slight repression with the individual miRNAs, but the level did not become 
significant until all three were present. Interestingly, CUL2 was upregulated in the presence 
of miR-23a, miR-24, or miR-27a, but showed a significant decrease in expression from the 
entire cluster. It is possible that the upregulation of the cluster caused a decrease in CUL2 
expression as a secondary target. The interesting nature of this change in expression 
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warrants further study. These results agree with previous findings that clustered miRNAs 
have synergistic effects on target genes28.
Target Algorithm Evaluation
Predicted target genes from algorithms including TargetScan37, microT38, PicTar39, 
miRDB40, and PITA7 were correlated with iTRAQ quantification data to evaluate their 
predictive abilities. The average log2 fold change for putative targets from all algorithms 
were negative for miR-23a and miR-27a, demonstrating that the majority of predictions were 
downregulated (Figure S5). Only miRDB predictions resulted in a negative average fold 
change for miR-24. Overall, miRDB predictions agreed most with our data for targets of 
miR-24 and miR-27a, while all algorithms performed similarly for miR-23a. Both 
TargetScan and miRDB heavily factor the presence of a miRNA binding site into their 
predictions, while weighing parameters such as free energy costs to a lesser degree. This 
consideration of miRNA seed site may be responsible for the accuracy of TargetScan and 
miRDB. Interestingly, when the predicted targets were analyzed for the cluster data set, a 
greater degree of repression was observed. This demonstrates the synergistic effect clustered 
miRNAs exhibit to decrease expression of target genes, even if they are not predicted to be 
regulated by multiple miRNAs.
Gene Ontology Analysis
To determine the biological relevance of miR-23a, miR-24, miR-27a, and the entire cluster, 
we ran each list of significantly altered proteins through the PANTHER (protein analysis 
through evolutionary relationships) database, which categorizes downregulated proteins 
according to their cellular compartment and molecular function (Figure S6)41. All data sets 
contained proteins localized to the nucleus, organelles, and organelle lumens. However, 
proteins downregulated by miR-23a also showed enriched localization to the mitochondria 
and chromosomes. Proteins that were repressed by miR-27a were found in the spliceosome 
and cytoplasmic dynein complex. When considering molecular functions, all miRNAs were 
found to regulate proteins involved in RNA binding. However, each miRNA also showed 
enrichment for unique molecular functions. Proteins regulated by miR-23a are involved in 
chromatin binding, translation initiation, and ATPase activity. MiR-24 proteins were 
enriched for lipoic acid binding and coenzyme binding. MiR-27a proteins play a role in 
structural constituents of the ribosome and cytoskeleton, and proteins downregulated by the 
entire cluster are involved in mRNA 3’-UTR binding. MiR-23a, miR-27a, and the entire 
cluster also showed enrichment for proteins involved in nucleotide binding.
These data sets were further analyzed using Reactome to determine which biological 
processes are strongly enriched (Supporting Information IV). The lists of downregulated 
proteins from each miRNA data set were submitted to the database and pathways with a p-
value below 0.05 were considered significant. Both miR-23a and miR-27a were found to 
repress proteins involved with global nucleotide excision repair, supporting previous 
findings that miR-23a protects against UVB damage through regulation of DNA damage 
pathways42. miR-23a and miR-27a are also responsible for regulating cell cycle checkpoints 
including the G2/M transition and S phase entry. The downregulation of cell cycle 
checkpoints was also evident when the entire cluster was overexpressed.miR-23a was found 
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to play a role in the SCF-FBXW7 ubiquitin ligase pathway by targeting Skp1a and Cul1. 
Interestingly, previous studies found miR-27a directly targets FBXW7 to increase the 
invasive abilities of colon cancer cells25. From this, we can infer that multiple members of 
the mirn23a cluster have the capacity to regulate different members of the same pathways. 
MiR-27a has been previously shown to decrease expression of the apoptotic protein BCL-2, 
while we found miR-27a to regulate apoptosis through repression of STK343. MiR-24 
appears to play a role in regulation of lipid metabolism through PPARα and glucose 
transport, which is entirely distinct from the other two miRNAs in the mirn23a cluster.
When considering the cluster as a whole, a number of pathways not enriched by any 
individual miRNA can be seen. For example, the mirn23a cluster data was enriched for 
proteins that activate WASPs and WAVEs, which regulate actin polymerization for cell 
motility44. In addition, the cluster represses proteins involved with insulin-like growth factor 
2 signaling, which are responsible for mitogenic activities and activation of the TGF-β 
pathway45. It is important to note that most of the pathways enriched by the mirn23a cluster 
were distinct from any enriched by miR-23a, miR-24, or miR-27a. From this analysis it is 
evident that the effects of the mirn23a cluster on the proteome differ from the effects of the 
individual miRNAs.
Validation of iTRAQ Quantification
We used multiple reaction monitoring (MRM) and RT-PCR to confirm iTRAQ quantification 
and identification of miRNA targets (Figure 6). Proteins found to be repressed by iTRAQ 
quantification were confirmed through MRMs in their direction and miRNA specificity. 
Confirmation by this additional technique validates our iTRAQ data sets. Transitions used 
for quantification can be found in Table S2. Furthermore, we performed quantitative RT-
PCR of genes that contain miRNA binding sites and are likely to be direct targets of these 
miRNAs (Table S3). We chose targets identified by proteomics that are predicted to be 
direct targets of miR-23a, miR-24, or miR-27a, or cluster targets. Mapre1, Nup210, Dhfr, 
and Slc7aF5 all showed downregulation of transcript expression by their specific miRNAs, 
indicating the miRNAs act through transcript degradation mechanisms. The cluster targets, 
Top1 and Tra2b, showed a significantly larger degree of repression when the entire cluster 
was overexpressed. Top1 exhibited a small degree of repression in the miR-23a data set. Two 
targets, Atxn10 and Chek1, only showed slight repression, indicating these genes are 
repressed through translational inhibition.
A number of miRNA targets detected in this study were chosen for confirmation of the 
presence of miRNA binding sites using 3’ Rapid Amplification of cDNA Ends (3’ RACE). 
The genes Nup210 and Med8 were found to have miR-24 binding sites, while Nln and 
Rap1b were shown to contain miR-27a seed matches, indicating repression likely occurs 
through traditional mechanisms (Figure S7). However, alternative polyadenylation is known 
to occur in up to 32% of murine transcripts, resulting in mRNAs that no longer contain 
predicted miRNA binding sites. This process can result in transcripts with multiple poly-A 
regions in the 3’ UTR, or poly-A regions that disrupt the coding sequences of mRNAs46. 
Alternative polyadenylation may be responsible for a number of false negatives in our study 
due to mRNA modifications in the 70Z/3 cell line.
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Conclusions
In this study, we examined the targets of miR-23a, miR-24, miR-27a, and the mirn23a 
cluster through quantitative iTRAQ UPLC-MS/MS. We identified between 60-160 targets 
for each condition, including a number of shared targets between miRNAs, and targets 
regulated by the entire cluster. The pathways identified for each miRNA may help to shed 
light on mechanisms of many biological processes and diseases that these miRNAs play a 
role in. We also demonstrated the importance of examining miRNA clusters in their entirety, 
because their physiological roles differ from those of individual miRNAs.
Although this study was conducted in a murine cell line, we believe our findings have 
implications in humans as well. The genomes of mice and humans only differ by 15%, and 
the mechanisms of miRNA biogenesis and function are conserved47,48. The mature 
sequences of miR-23a, miR-24, and miR-27a are identical in both species15. The synergistic 
effect of miRNA clusters on the proteome described here is known to exist in both mice and 
humans, and therefore our work likely translates between these species28.
Based on our proteomic studies of miRNA clusters, it is essential that predictive algorithms 
for miRNA targets factor the clustering of miRNAs into target predictions for increased 
accuracy. Future studies will discern primary and secondary targets of the miRNAs, as well 
as proteins that interact with and regulate the mirn23a cluster.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
miR-23a/27a/24-2 levels in 70Z/3 cells. (A) Sequences of mature miRNAs in humans and 
mice. Seed sequences are indicated in red. (B) Taqman qRT-PCR of miRNA levels in 70Z/3 
cell lines. Data represented as average + SD.
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Figure 2. 
Overview of experimental design. Biological replicates of 70Z/3 cells were harvested for 
protein and digested with trypsin. Each sample was labeled with a particular iTRAQ tag and 
combined for UPLC-MS/MS analysis. Tandem mass spectra allow for identification of 
peptides and quantification from iTRAQ reporter ions.
Ludwig et al. Page 16
J Proteome Res. Author manuscript; available in PMC 2017 May 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. 
Histograms displaying log2 iTRAQ fold change ratios. Differentially regulated proteins are 
indicated in red.
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Figure 4. 
Targets detected by quantitative iTRAQ mass spectrometry for (A) miR-23a (B) miR-24 and 
(C) miR-27a. (D) Proteins found to be downregulated by multiple miRNAs. These proteins 
were found to be significantly downregulated through iTRAQ quantification after 
overexpression of each miRNA.
Ludwig et al. Page 18
J Proteome Res. Author manuscript; available in PMC 2017 May 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. 
Heat map displaying genes that only showed significant repression in the presence of the 
entire cluster. Green indicates downregulation, while red indicates upregulation. All values 
were derived from iTRAQ quantification.
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Figure 6. 
Multiple reaction monitoring confirmation of iTRAQ quantification. MRM measurements 
are shown in blue and iTRAQ measurements were shown in red. All values are represented 
as the Log2 ± SD.
Ludwig et al. Page 20
J Proteome Res. Author manuscript; available in PMC 2017 May 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Ludwig et al. Page 21
Table 1
Summary of Peptide and Protein Identifications through iTRAQ-UPLC-MS/MS
Experiment MS/MS PSMS % Identification Peptides Proteins
miR-23a 142,517 43,085 30.2 11,417 1,991
miR-24 140,995 41,806 29.6 10,736 1,942
miR-27a 164,933 47,309 28.6 11,848 2,127
Cluster 168,585 48,379 28.7 11,491 2,099
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